Cargando…
Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine
This potentially life-threatening disease poses an interesting perspective on adverse events that can occur or can be exacerbated following the Ad26.COV2.S (Johnson & Johnson) vaccine. The authors report findings in a 65-year-old female patient who experienced facial diplegia, an atypical varian...
Autores principales: | Jain, Esha, Pandav, Krunal, Regmi, Pratima, Michel, George, Altshuler, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381448/ https://www.ncbi.nlm.nih.gov/pubmed/34447646 http://dx.doi.org/10.7759/cureus.16612 |
Ejemplares similares
-
Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
Publicado: (2022) -
Isolated facial diplegia: A rare presentation of Guillain‐Barre syndrome
por: Sardar, Sundus, et al.
Publicado: (2021) -
Facial diplegia with hyperreflexia-a mild Guillain-Barre Syndrome variant, to treat or not to treat?
por: Sethi, Nitin K, et al.
Publicado: (2007) -
The Ultimate Poker Face: A Case Report of Facial Diplegia, a Guillain-Barré Variant
por: Lowe, Joshua, et al.
Publicado: (2020) -
Loss of Taste as an Initial Symptom of a “Facial Diplegia and Paresthesia” Variant of Guillain-Barré Syndrome
por: Hiraga, Akiyuki, et al.
Publicado: (2022)